Silva Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
Silva Pharmaceuticals has a total shareholder equity of BDT2.3B and total debt of BDT42.2M, which brings its debt-to-equity ratio to 1.8%. Its total assets and total liabilities are BDT2.5B and BDT157.6M respectively.
Key information
1.8%
Debt to equity ratio
৳42.24m
Debt
| Interest coverage ratio | n/a |
| Cash | ৳178.53m |
| Equity | ৳2.31b |
| Total liabilities | ৳157.59m |
| Total assets | ৳2.47b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SILVAPHL's short term assets (BDT1.0B) exceed its short term liabilities (BDT75.8M).
Long Term Liabilities: SILVAPHL's short term assets (BDT1.0B) exceed its long term liabilities (BDT81.8M).
Debt to Equity History and Analysis
Debt Level: SILVAPHL has more cash than its total debt.
Reducing Debt: SILVAPHL's debt to equity ratio has increased from 0% to 1.8% over the past 5 years.
Debt Coverage: SILVAPHL's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if SILVAPHL's interest payments on its debt are well covered by EBIT.